EOLS 8-K 2026-07-08

Evolus, Inc. (EOLS) 8-K dated 2026-07-08 — accession 0001570562-26-000079. This URL is the filing, not the EOLS hub.

Evolus, Inc. (EOLS) is a drug manufacturers - specialty & generic company listed on US.

Evolus, Inc. filed a 8-K on 2026-07-08. Accession 0001570562-26-000079.

Cached items: 1.01, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported EOLS revenue for 2026-06-30 was $157.2M. Net income was -$18.7M. EOLS currently screens at market cap $597.0M.

Not investment advice. The EOLS SEC hub lists recent forms. The stock page is the research view.